TG Therapeutics Inc (LTS:0VGI)
$ 23.452 0.002 (0.01%) Market Cap: 3.59 Bil Enterprise Value: 3.49 Bil PE Ratio: 38.45 PB Ratio: 20.11 GF Score: 76/100

Q3 2022 TG Therapeutics Inc Earnings Call Transcript

Nov 10, 2022 / 01:30 PM GMT
Release Date Price: $8.42 (+31.43%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TGTX.OQ - TG Therapeutics Inc
Q3 2022 TG Therapeutics Inc Earnings Call
Nov 10, 2022 / 01:30PM GMT

=====================
Conference Call Participants
=====================
* >>Jenna Bosco - Head of Corporate Communications
* >>Michael Weiss - CEO
* >>Adam Waldman - Senior Key Executive
* >>Sean Power - CFO
* >>Edward White - H.C. Wainwright & Co, LLC, Research Division
* >>Christopher Howerton - Jefferies LLC, Research Division
* >>Matthew Kaplan - Ladenburg Thalmann & Co. Inc., Research Division
* >>Eric Joseph - JPMorgan Chase & Co, Research Division
* >>Sahil Kazmi - B. Riley Securities, Inc., Research Division
* >>Graig Suvannavejh - Goldman Sachs Group, Inc., Research Division
* >>Joshua Schimmer - Evercore ISI Institutional Equities, Research Division
* >>Prakhar Agrawal - Cantor Fitzgerald & Co., Research Division

=====================
Presentation
--------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot